Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Lipid Metabolism Disorders
Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system (enzymes) break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues. If you have a metabolic disorder, something goes wrong with this process.
Lipid metabolism disorders, such as Gaucher disease and Tay-Sachs disease, involve lipids. Lipids are fats or fat-like substances. They include oils, fatty acids, waxes, and cholesterol. If you have one of these disorders, you may not have enough enzymes to break down lipids. Or the enzymes may not work properly and your body can't convert the fats into energy. They cause a harmful amount of lipids to build up in your body. Over time, that can damage your cells and tissues, especially in the brain, peripheral nervous system, liver, spleen, and bone marrow. Many of these disorders can be very serious, or sometimes even fatal.
These disorders are inherited. Newborn babies get screened for some of them, using blood tests. If there is a family history of one of these disorders, parents can get genetic testing to see whether they carry the gene. Other genetic tests can tell whether the fetus has the disorder or carries the gene for the disorder.
Enzyme replacement therapies can help with a few of these disorders. For others, there is no treatment. Medicines, blood transfusions, and other procedures may help with complications.
It sits within Metabolic Problems.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Lipid Metabolism Disorders
5,135 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Caregiving Networks Across Disease Context and the Life CourseNational Human Genome Research Institute (NHGRI)
- Hepatic Lipid Metabolism-Alcohol Use DisorderNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Impact of MBS on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese PatientsAll India Institute of Medical Sciences, Bhubaneswar
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisAzafaros B.V.
- Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease PatientsUniversity of Lahore
- Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic HyperlipidemiaNational Heart, Lung, and Blood Institute (NHLBI)
Research already completed
- Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy VolunteersJiangsu HengRui Medicine Co., Ltd.
- Alleviation of Hypercholesterolemia Through Newly Developed Cookies Supplementedwithpumpkin (Cucurbita Pepo L.) Seeds and Walnuts (Juglans Regia L.) Among Arthrosclerosispatients.Kamran Hanif
- Cardiovascular Evaluation of Patients With High Cholesterol and Normal VolunteersNational Heart, Lung, and Blood Institute (NHLBI)
- A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.Novartis Pharmaceuticals
- A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)Regeneron Pharmaceuticals
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- Lipid Storage DiseasesNational Institute of Neurological Disorders and Stroke
Diagnosis and Tests
- Genetic Testing: MedlinePlus Health TopicNational Library of Medicine
Genetics
- 3-hydroxyacyl-CoA dehydrogenase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Carnitine palmitoyltransferase I deficiency: MedlinePlus GeneticsNational Library of Medicine
- Carnitine palmitoyltransferase II deficiency: MedlinePlus GeneticsNational Library of Medicine
- Carnitine-acylcarnitine translocase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Cerebrotendinous xanthomatosis: MedlinePlus GeneticsNational Library of Medicine
- Chanarin-Dorfman syndrome: MedlinePlus GeneticsNational Library of Medicine
- Combined malonic and methylmalonic aciduria: MedlinePlus GeneticsNational Library of Medicine
- Fabry disease: MedlinePlus GeneticsNational Library of Medicine
- Familial hypercholesterolemia: MedlinePlus GeneticsNational Library of Medicine
- Familial hypobetalipoproteinemia: MedlinePlus GeneticsNational Library of Medicine
- Familial lipoprotein lipase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Farber lipogranulomatosis: MedlinePlus GeneticsNational Library of Medicine
- Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Lysosomal acid lipase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Malonyl-CoA decarboxylase deficiency: MedlinePlus GeneticsNational Library of Medicine
- Medium-chain acyl-CoA dehydrogenase deficiency: MedlinePlus GeneticsNational Library of Medicine
- MEGDEL syndrome: MedlinePlus GeneticsNational Library of Medicine
- Methylmalonic acidemia with homocystinuria: MedlinePlus GeneticsNational Library of Medicine
- Methylmalonic acidemia: MedlinePlus GeneticsNational Library of Medicine
- Mucolipidosis type IV: MedlinePlus GeneticsNational Library of Medicine
- Neutral lipid storage disease with myopathy: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: Lipid Metabolism DisordersNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Lipid Metabolism, Inborn Errors, Lipid Metabolism Disorders. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Lipid Metabolism Disorders, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.